Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
55.58
+1.02 (1.87%)
At close: Mar 4, 2026, 4:00 PM EST
55.52
-0.06 (-0.11%)
After-hours: Mar 4, 2026, 7:50 PM EST
Supernus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Supernus Pharmaceuticals stock have an average target of 61.6, with a low estimate of 55 and a high estimate of 65. The average target predicts an increase of 10.83% from the current stock price of 55.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 19, 2025.
Analyst Ratings
The average analyst rating for Supernus Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $50 → $55 | Hold | Maintains | $50 → $55 | -1.04% | Dec 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +16.95% | Oct 29, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | +7.95% | Oct 23, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $40 → $65 | Hold → Buy | Upgrades | $40 → $65 | +16.95% | Oct 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $46 → $63 | Buy | Maintains | $46 → $63 | +13.35% | Sep 30, 2025 |
Financial Forecast
Revenue This Year
885.71M
from 718.95M
Increased by 23.19%
Revenue Next Year
1.04B
from 885.71M
Increased by 17.65%
EPS This Year
1.96
from -0.68
EPS Next Year
4.88
from 1.96
Increased by 148.79%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 931.1M | 1.1B | |||
| Avg | 885.7M | 1.0B | |||
| Low | 838.1M | 947.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 29.5% | 26.2% | |||
| Avg | 23.2% | 17.6% | |||
| Low | 16.6% | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.78 | 9.00 | |||
| Avg | 1.96 | 4.88 | |||
| Low | 1.02 | 2.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 358.7% | |||
| Avg | - | 148.8% | |||
| Low | - | 6.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.